The May 14 GHK-Cu update and the April 30 GLP-1 proposal are separate policy actions, but they read together as one signal: FDA is actively curating both lists, and the regulatory ceiling for peptide compounding is being lowered for some substances and held for others
Compounded medications are prescribed based on a licensed provider's medical judgment, following a consultation and review of the patient's medical history
Others are living with diabetes, high blood pressure, or sleep apnea and need medical support while losing weight
Monitoring your Mental Health While on Semaglutide (Ozempic or Wegovy): If you have a history of depression, anxiety, or other mental health issues, its important to disclose this to your doctor so you can determine whether starting Ozempic is right for you
While medications like Semaglutide and Tirzepatide provide powerful tools for weight reduction, they are just one part of a larger approach